Antibodies
30 March 2015
Cardio3 BioSciences Successfully Completes Futility Analysis of Lead Cardiac Cell Therapy, C-Cure(R)30 March 2015
Biogen Announces EMA Validation of Marketing Authorization Application for SB2, a Biosimilar Candidate for Infliximab27 March 2015
Aridis Pharmaceuticals Commences Phase 1 Clinical Study of Aerucin™ Monoclonal Antibody for Acute Pneumonia23 March 2015
Genmab Retains Partial Rights for HuMax-TAC-ADC — Will Not Exercise Co-development Right23 March 2015
Novartis’ Cosentyx(TM) two-year data shows sustained effect and favorable safety profile in psoriasis patients17 March 2015
Ablynx initiates the first of two phase IIb RA studies with its anti-IL-6R nanobody, partnered with Abbvie16 March 2015
ADC Therapeutics Submits its First IND For a Novel Antibody Drug Conjugate Against LymphomasNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports